Sarah Cannon Research Institute Dept of Onc — Nashville, Tennessee

Sarah Cannon Research Institute Dept of Onc is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute Dept of Onc has participated in 2 clinical trials.

Therapeutic areas: Solid Tumors, CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute Dept of Onc?

Sarah Cannon Research Institute Dept of Onc has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute Dept of Onc conducted?

Sarah Cannon Research Institute Dept of Onc has 2 clinical trials on record. Their work covers Solid Tumors, CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma.

Is Sarah Cannon Research Institute Dept of Onc accredited by Crixeo Health?

Sarah Cannon Research Institute Dept of Onc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute Dept of Onc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.